In-situ coronary thrombosis without atherosclerosis in a young male: A case of multifactorial thrombophilia

Abstract We present the case of a 27-year-old male with an acute anterior Q-wave myocardial infarction due to in-situ thrombosis of the left anterior descending artery (LAD), with no angiographic signs of atherosclerosis. The clinical presentation revealed a multifactorial etiology involving immune activation (positive lupus anticoagulant, high SARS-CoV-2 IgG), genetic predisposition (heterozygous mutations in MTHFR, MTRR, PAI-1), and modifiable factors (smoking, stress). The case highlights diagnostic challenges in young patients without traditional risk factors, as well as the importance of adhering to validated APS testing protocols. Particular attention is drawn to the premature switch from warfarin to edoxaban, prompting reconsideration of anticoagulation strategy in the context of suspected APS. This report emphasizes the need for individualized evaluation and treatment planning in atypical arterial thrombosis, especially in the context of potential post-COVID immune dysregulation.

Authors

Institutions

Publication Details

Journal
Romanian Journal of Cardiology
Published
2025-09-01
DOI
https://doi.org/10.2478/rjc-2025-0024
Primary Topic
Blood Coagulation and Thrombosis Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In-situ coronary thrombosis without atherosclerosis in a young male: A case of multifactorial thrombophilia

Vasilyeva Larisa Ivanovna, Kalashnikova Oksana Sergeevna
Romanian Journal of Cardiology
Blood Coagulation and Thrombosis Mechanisms
article

In-situ coronary thrombosis without atherosclerosis in a young male: A case of multifactorial thrombophilia

Vasilyeva Larisa Ivanovna, Kalashnikova Oksana Sergeevna
article en

Abstract

Abstract We present the case of a 27-year-old male with an acute anterior Q-wave myocardial infarction due to in-situ thrombosis of the left anterior descending artery (LAD), with no angiographic signs of atherosclerosis. The clinical presentation revealed a multifactorial etiology involving immune activation (positive lupus anticoagulant, high SARS-CoV-2 IgG), genetic predisposition (heterozygous mutations in MTHFR, MTRR, PAI-1), and modifiable factors (smoking, stress). The case highlights diagnostic challenges in young patients without traditional risk factors, as well as the importance of adhering to validated APS testing protocols. Particular attention is drawn to the premature switch from warfarin to edoxaban, prompting reconsideration of anticoagulation strategy in the context of suspected APS. This report emphasizes the need for individualized evaluation and treatment planning in atypical arterial thrombosis, especially in the context of potential post-COVID immune dysregulation.

Romanian Journal of CardiologyVol. 35(3)
Dnipro University of Technology (UA), Dnipro State Medical University (UA)
Openalex Percentile: Top 69%
Blood Coagulation and Thrombosis Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.